Latest news
US FDA accepts supplemental Biologics License Application for Merck’s Enflonsia - PMLiVEPMLiVE · Fri, 07 Aug 2026 10:55:00 GMTLilly’s olomorasib gets FDA Breakthrough Therapy designation for pancreatic cancer - PMLiVEPMLiVE · Tue, 04 Aug 2026 10:55:00 GMTNovartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer - PMLiVEPMLiVE · Mon, 03 Aug 2026 11:55:35 GMT